Clinical Indication ID & Name
M243
Thymic Carcinoma
Test Group
Solid Tumours (Adult)
Specialties
Test code
M243.1
Test name
Multi-target NGS panel (KIT)
Target genes
KIT
Test scope
Small variant detection
Test method/ technology
Panel
Optimal Family Structure
n/a
Eligibility Criteria
KIT proto-oncogene receptor tyrosine kinase gene (KIT) testing in confirmed Thymic Carcinoma cases where the treating clinician considers the patient would benefit from treatment with imatinib AND there is a reasonable expectation that the patient will be able to access Imatinib.
Commissioning group
n/a
Overlapping idications
n/a
Address for samples/request forms
North Thames GLH, Rare & Inherited Disease Genomic Laboratory
Specimen Reception, Level 5 Barclay House, 37 Queen Square,
London WC1N 3BH
Contact with queries
Supporting documents
n/a
Education resources
n/a
Service updates
n/a
Request form download
Consent record
See consent guidance in test request form
Sample requirements
See sample guidance in test request form